Related Experiment Video
Updated: Jul 9, 2026

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS
Published on: November 8, 2024
The federal Drug Enforcement Administration "prescription series" proposal: continuing concerns
Aaron M Gilson1, David E Joranson
1U.S. Policy Research, World Health Organization Collaborationg Center for Policy and Communications in Cancer Care, University of Wisconsin-Madison, 406 Science Drive, Suite 202, Madison, WI 53711-1068, USA. amgilson@wisc.edu
Abstract:
Two leading health and pain policy analysts discuss the implications of the federal Drug Enforcement Administration proposed position on the legality of practitioners writing series of controlled substance prescriptions for the purpose of providing ongoing pain management without the necessity for unneeded patient visits to their prescribers. This issue led to a series of regulatory proposals that engendered great concern in the pain management community. The proposed positive outcome from the DEA is described.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Classes and Categories
Pharmaceutical Poisoning: Potential Scenarios
Drug Dosing: Geriatric Patients

